Roivant Sciences Ltd. [NASDAQ: ROIV] loss -8.65% on the last trading session, reaching $11.51 price per share at the time. The company report on August 17, 2023 at 4:05 PM that Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants.
On August 2, 2023, Roivant announced the redemption of all of its outstanding Warrants to purchase Common Shares pursuant to its Warrant Agreement dated September 30, 2021 with Equiniti Trust Company, LLC (formerly American Stock Transfer & Trust Company, LLC) as successor warrant agent (the “Warrant Agent”) (the “Warrant Agreement”), that remain outstanding following 5:00 p.m. New York City Time on September 1, 2023 (the “Redemption Date”) for a redemption price of $0.10 per Warrant (the “Redemption Price”). The Warrant Agent previously delivered the notice of redemption (the “Notice of Redemption”) to each of the registered holders of the outstanding Warrants on behalf of Roivant.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Roivant Sciences Ltd. represents 759.27 million in outstanding shares, while the company has a total market value of $8.25 billion with the latest information. ROIV stock price has been found in the range of $11.3122 to $12.84.
If compared to the average trading volume of 5.10M shares, ROIV reached a trading volume of 6628421 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Roivant Sciences Ltd. [ROIV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $15.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Roivant Sciences Ltd. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on June 08, 2023.
The Average True Range (ATR) for Roivant Sciences Ltd. is set at 0.57, with the Price to Sales ratio for ROIV stock in the period of the last 12 months amounting to 104.94. The Price to Book ratio for the last quarter was 9.59, with the Price to Cash per share for the same quarter was set at 2.00.
Trading performance analysis for ROIV stock
Roivant Sciences Ltd. [ROIV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.46. With this latest performance, ROIV shares gained by 1.05% in over the last four-week period, additionally plugging by 50.46% over the last 6 months – not to mention a rise of 211.92% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ROIV stock in for the last two-week period is set at 50.91, with the RSI for the last a single of trading hit 48.90, and the three-weeks RSI is set at 52.20 for Roivant Sciences Ltd. [ROIV]. The present Moving Average for the last 50 days of trading for this stock 11.29, while it was recorded at 11.87 for the last single week of trading, and 8.99 for the last 200 days.
Roivant Sciences Ltd. [ROIV]: A deeper dive into fundamental analysis
Reflecting on the efficiency of the workforce at the company, Roivant Sciences Ltd. [ROIV] managed to generate an average of -$193,201 per employee.Roivant Sciences Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.40 and a Current Ratio set at 6.40.
An analysis of Institutional ownership at Roivant Sciences Ltd. [ROIV]
The top three institutional holders of ROIV stocks are: VANGUARD GROUP INC with ownership of 1.31 billion shares, which is approximately 8.2089%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $170.67 trillion in ROIV stocks shares; and BERKSHIRE HATHAWAY INC, currently with $150.98 trillion in ROIV stock with ownership which is approximately 5.7381%.
